230: IVIG for refractory HIT, differences in QTc risk among quinolones, and a resource for searching FDA reports of adverse reactions to medications

Published: Oct. 2, 2017, 7 a.m.

Show notes at pharmacyjoe.com/episode230. In this episode I ll: 1. Discuss an article about using IVIG for refractory HIT. 2. Answer the drug information question “Do some quinolones have lower QTc prolongation risk than others?” 3. Share a resource for searching FDA reports of adverse reactions to medications. The post 230: IVIG for refractory HIT, differences in QTc risk among quinolones, and a resource for searching FDA reports of adverse reactions to medications appeared first on Pharmacy Joe.